Literature DB >> 32036500

Anti-decubitus bed mattress may interfere with cerebrovascular pressure reactivity measures due to induced ICP and ABP cyclic peaks.

Tas Jeanette1, Borg Melisa2, Smielewski Peter3, Czosnyka Marek3, Beqiri Erta4, Ercole Ari5, Aries Marcel2.   

Abstract

Severe traumatic brain injury (TBI) patients are monitored with continuous arterial blood pressure (ABP) and intracranial pressure (ICP). The pressure reactivity index (PRx) is a frequently used correlation coefficient between ABP and ICP to inform clinicians at the bedside about trends in global cerebrovascular pressure regulation status. We present an unexpected influence of cyclic anti-decubitus mattress inflations and deflations on invasive ICP, ABP and PRx calculations in our TBI patients. This might affect autoregulation guided management. In our database, 23% (9/39) of the patients show recurrent peaks in the monitoring signals. We hypothesize that these peaks are caused by (a combination) of hydrostatic change, local (cervical) compression and/or incorrect sensor zeroing due to positional changes induced by the anti-decubitus mattress. This warrants further investigation by the manufacturer and exploration of data filters.

Entities:  

Keywords:  Anti-decubitus bed mattress; ICP; Prx

Year:  2020        PMID: 32036500     DOI: 10.1007/s10877-020-00471-5

Source DB:  PubMed          Journal:  J Clin Monit Comput        ISSN: 1387-1307            Impact factor:   2.502


  2 in total

1.  Continuous monitoring of cerebrovascular pressure reactivity after traumatic brain injury in children.

Authors:  Ken M Brady; Donald H Shaffner; Jennifer K Lee; R Blaine Easley; Peter Smielewski; Marek Czosnyka; George I Jallo; Anne-Marie Guerguerian
Journal:  Pediatrics       Date:  2009-12       Impact factor: 7.124

2.  Feasibility of individualised severe traumatic brain injury management using an automated assessment of optimal cerebral perfusion pressure: the COGiTATE phase II study protocol.

Authors:  Erta Beqiri; Peter Smielewski; Chiara Robba; Marek Czosnyka; Manuel Teixeira Cabeleira; Jeanette Tas; Joseph Donnelly; Joanne G Outtrim; Peter Hutchinson; David Menon; Geert Meyfroidt; Bart Depreitere; Marcel J Aries; Ari Ercole
Journal:  BMJ Open       Date:  2019-09-20       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.